Diagnosis
12:20
Moderator: Christopher Porter, Vice President, Government Affairs and Policy, Travere Therapeutics
Natasha Bonhomme, Chief Strategy Officer, Genetic Alliance, Founder, Expecting Health
Nicole Miller, Vice President, Molecular Diagnostics, Global Medical Affairs, Ultragenyx
Kate Donigan, Senior Director, Science & Regulatory Policy, Global Policy, Government, & Patient Affairs, Sarepta Therapeutics
Tom Defay, Deputy Head Diagnostics Strategy & Development, Alexion Pharmaceuticals